{"symbol": "EVGN", "name": "Evogene Ltd.", "next_earnings_utc": 1590490800, "next_earnings_period_start_date_utc": 1577750400, "next_earnings_period_end_date_utc": 1585612800, "next_earnings_has_time": true, "next_earnings_name": "2020 Q1", "next_earnings_year": 2020, "next_earnings_quarter": 1, "next_earnings_revenue_num_analysts": null, "next_earnings_revenue_consensus": null, "next_earnings_eps_num_analysts": null, "next_earnings_eps_consensus": null, "eps_up_revisions": null, "eps_down_revisions": null, "revenue_up_revisions": null, "revenue_down_revisions": null, "total_analysts": 0, "analysts_sell": null, "analysts_buy": null, "analysts_outperform": null, "analysts_hold": null, "analysts_underperform": null, "webpage": "evogene.com", "year_founded": 1999, "street_address": "13 Gad Feinstein Street", "city": "Rehovot", "state": null, "zipcode": "7612002", "country": "Israel", "phone_number": "972 8 931 1900", "short_description": "Evogene Ltd., a biotechnology company, engages in developing various products for life science markets through the use of computational predictive biology platform in the United States, Israel, Germany, Brazil, and internationally.", "long_description": "Evogene Ltd., a biotechnology company, engages in developing various products for life science markets through the use of computational predictive biology platform in the United States, Israel, Germany, Brazil, and internationally. The company operates through three segments: Agriculture, Human Health, and Industrial Applications. The Agriculture segment develops seed traits, ag-chemical products, and ag-biological products to enhance plant performance. Its products focus on various crops, such as corn, soybean, wheat, rice, and cotton. The Industrial Application segment develops enhanced castor bean seeds to serve as a feedstock source for industrial uses. The Human Health segment discovers and develops human microbiome-based therapeutics for the treatment of immuno-oncology, GI related disorders, and multi drug resistant organisms. The company also provides medical cannabis products. The company has strategic collaborations and licensing agreements with agricultural companies, such as BASF, Corteva, Bayer, and ChemChina. Evogene Ltd. was founded in 1999 and is headquartered in Rehovot, Israel.", "industry_name": "Biotechnology", "sector_name": "Health Care", "is_defunct": false, "exchange": "NASDAQ", "equity_type": "stocks", "market_cap": 28088943, "total_enterprise": -5119102, "number_of_employees": 143, "outstanding_shares": 25754297, "eps": -0.703261, "diluted_eps": -0.703261, "earnings_from_cont_operations": -19115000, "gross_profit": 419000, "cash": 46876000, "total_debt": 2971000, "total_revenue": 753000, "cash_from_operations": -17666000, "net_income": -18112000, "ebitda": -19164000, "year_low_stock_price": 0.75, "year_high_stock_price": 1.83, "stocktwits_watchlist_count": 294, "image_url": "https://raw.githubusercontent.com/earnbros/earnbros.github.io/master/api/images/companies/EVGN.png"}